J Korean Med Sci.
2009 Feb;24(1):188-188. 10.3346/jkms.2009.24.1.188.
Authors' Reply to "Is Hib Vaccine of Economic Value in South Korea?"
- Affiliations
-
- 1Department of Health Care Management and Policy, Seoul National University, School of Public Health, Seoul, Korea.
- 2Department of Preventive Medicine, Hanyang University, College of Medicine, Seoul, Korea. yshin@hanyang.ac.kr
- 3Department of Preventive Medicine, Eulji University, School of Medicine, Daejeon, Korea.
- KMID: 1794433
- DOI: http://doi.org/10.3346/jkms.2009.24.1.188
Abstract
- No abstract available.
Reference
-
1. Shin S, Shin Y, Ki M. Cost-benefit analysis of haemophilus influenzae type B immunization in Korea. J Korean Med Sci. 2008. 23:176–184.
Article2. Kim JS, Jang YT, Kim JD, Park TH, Park JM, Kilgore PE, Kennedy WA, Park E, Nyambat B, Kim DR, Hwang PH, Kim SJ, Eun SH, Lee HS, Cho JH, Kim YS, Chang SJ, Huang HF, Clemens JD, Ward JI. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children. Vaccine. 2004. 22:3952–3962.
Article3. Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis. Pediatrics. 2002. 110:653–661.
Article
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Present status and prospects of Haemophilus influenzae type b(Hib) immunization
- Haemophilus influenzae type b Vaccine
- Cost-Benefit Analysis of Haemophilus Influenzae Type B Immunization in Korea
- Paths toward hepatitis B immunization in South Korea and Taiwan
- Is Hib Vaccine of Economic Value in South Korea?
